Navigation Links
Micromet to Present at the Piper Jaffray 20th Annual Health Care Conference
Date:11/26/2008

r from any future results expressed or implied by such forward-looking statements. These forward-looking statements include statements regarding the efficacy, safety and intended utilization of our product candidates, the development of our BiTE antibody technology, the conduct, timing and results of future clinical trials, expectations of the future expansion of our product pipeline and collaborations, and our plans regarding future presentations of clinical data. You are urged to consider statements that include the words "ongoing," "may," "will," "believes," "potential," "expects," "plans," "anticipates," "intends," or the negative of those words or other similar words to be uncertain and forward-looking. Factors that may cause actual results to differ materially from any future results expressed or implied by any forward-looking statements include the risk that product candidates that appeared promising in early research, preclinical studies or clinical trials do not demonstrate safety and/or efficacy in subsequent clinical trials, the risk that encouraging results from early research, preclinical studies or clinical trials may not be confirmed upon further analysis of the detailed results of such research, preclinical study or clinical trial, the risk that additional information relating to the safety, efficacy or tolerability of our product candidates may be discovered upon further analysis of preclinical or clinical trial data, the risk that we or our collaborators will not obtain approval to market our product candidates, the risks associated with reliance on outside financing to meet capital requirements, and the risks associated with reliance on collaborators, including MedImmune, Merck Serono, TRACON and Nycomed, for the funding or conduct of further development and commercialization activities relating to our product candidates. These factors and others are more fully discussed in Micromet's Annual Report on Form 10-K for the fiscal year ended December 3
'/>"/>
SOURCE Micromet, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Micromet Receives Regulatory Approval to Conduct a Phase 2 Clinical Trial Investigating MT103 (MEDI-538) in Patients with Acute Lymphoblastic Leukemia
2. Micromets BiTE(R) Antibodies Reveal Unique Mode of Action
3. Micromet and MedImmune to Present New Clinical Data for Anti-CD19 BiTE(R) Antibody at American Society of Hematology Annual Meeting Showing Objective Clinical Responses in Relapsed Non-Hodgkins Lymphoma Patients
4. Micromet, Inc. Reports First Quarter 2008 Financial Results
5. Micromet, Inc. Reports Second Quarter 2008 Financial Results
6. AtriCure to Present at Thomas Weisel Partners 2007 Healthcare Conference
7. Matrixx Initiatives, Inc. to Present at the Roth Capital Partners 2007 New York Conference
8. BD to Present at the Bear Stearns 20th Annual Healthcare Conference
9. ATS Medical to Present at the 2007 Thomas Weisel Partners Healthcare Conference
10. Omnicell to Present at Thomas Weisel Healthcare Conference 2007
11. AtriCure to Present at Roth Capital Partners 2007 New York Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2015)... Pitching speed, player’s height, and pitching for multiple teams ... according to new research released today at the American Orthopaedic ... “Our findings indicate that a 10 inch increase in height ... history of injury, a 10 mile per hour increase in ... history of injury, and playing for more than one team ...
(Date:3/28/2015)... How best to treat and recover ... orthopaedic medicine. While diagnostic hip injections are commonly performed ... etiology, research presented today at the American Orthopaedic Society ... that pain relief from this diagnostic injection may not ... “Our study looked to assess if the amount of ...
(Date:3/28/2015)... 2015 Early surgery may not be ... AC joint injuries, according to new research from Tripler ... American Orthopaedic Society for Sports Medicine’s ( AOSSM ) ... when surgery was not performed. , The final study ... treatment and 17 receiving non-surgical therapy. Of the non-surgery ...
(Date:3/28/2015)... California (PRWEB) March 28, 2015 Andrew Hawley ... original 1960's Who psychedelic concert posters. The Who and the ... York on August 2, 1968. According to Hawley, “The Who ... many concert halls and college campuses. Perhaps the most famous ... with Jim Morrison and the Doors on August 2, 1968 ...
(Date:3/28/2015)... Aureus Medical Group (web: aureusmedical.com), a ... jobs, has announced that it will participate as ... Annual Conference to be held April 10-11, 2015 ... OH. , The OPTA Annual Conference offers ... and services. , Representatives from Aureus Medical’s ...
Breaking Medicine News(10 mins):Health News:Researchers Highlight Shoulder and Elbow Injury Possibility in Youth Players 2Health News:Pain Injections for Hip Arthroscopy Patients May Not Predict Surgical Outcomes 2Health News:For Type V AC Joint Injuries, Early Surgery May Not Be the Best Approach 2Health News:Avid Collector from Vintage Rock Posters, Inc. Announces His Search For Original 1960's Who Psychedelic Concert Posters. 2Health News:Healthcare Staffing Leader, Aureus Medical Group, to Exhibit at the Ohio Physical Therapy Association Annual Conference 2
... TORRANCE (May 21, 2008) The American ... has recognized Marianne Gausche-Hill, M.D., FACEP, and Robert ... an honor the organization bestows upon emergency physicians ... their communities and their patients. , The ...
... for a lengthy period provided researcher Suzanne Nooij with ... and disorientation experienced by many astronauts. Nooij defended her ... Technology (TU Delft, The Netherlands) on Tuesday 20 May. ... orientation. Changes in gravitational forces, such as the transition ...
... Decision Making, INDIANAPOLIS, May 21 Eli Lilly ... its executive leadership,structure as the company continues to position ... "Earlier this year I asked each of our ... determine if they were optimally structured to,meet the demands ...
... WASHINGTON, May 21 Secretary of Veterans,Affairs Dr. James ... two special panels that will make recommendations on ways ... in suicide prevention,suicide research and suicide education., "There ... of even one of,the great men or women who ...
... Inc. (OTC,Bulletin Board: MMGP) reported on May 20, 2008, in ... income of $2,019,862 for,the quarter ending March 31, 2008, which ... the same time period last year, the Company,reported income of ... 31, 2008 and 2007 were,$685,663 and $247,954, respectively. The increase ...
... ... ... Waste to Energy, BEIJING and LAS VEGAS, May 21 /Xinhua-PRNewswire-FirstCall/ ... company, and its subsidiaries that engage in multiple,China-focused business activities including ...
Cached Medicine News:Health News:2 LA BioMed researchers named Heroes of Emergency Medicine 2Health News:Why do astronauts suffer from space sickness? 2Health News:Lilly Announces Changes in Key Leadership Roles 2Health News:Lilly Announces Changes in Key Leadership Roles 3Health News:Lilly Announces Changes in Key Leadership Roles 4Health News:Lilly Announces Changes in Key Leadership Roles 5Health News:VA Secretary Appoints Panel of National Suicide Experts 2Health News:MM2 Group Reports Record Net Income of $2,019,862 for Quarter Ending March 31, 2008 2Health News:China Holdings Announces Development on TaiHu and Ongniute Biomass Power Plants/Projects 2Health News:China Holdings Announces Development on TaiHu and Ongniute Biomass Power Plants/Projects 3Health News:China Holdings Announces Development on TaiHu and Ongniute Biomass Power Plants/Projects 4Health News:China Holdings Announces Development on TaiHu and Ongniute Biomass Power Plants/Projects 5Health News:China Holdings Announces Development on TaiHu and Ongniute Biomass Power Plants/Projects 6Health News:China Holdings Announces Development on TaiHu and Ongniute Biomass Power Plants/Projects 7Health News:China Holdings Announces Development on TaiHu and Ongniute Biomass Power Plants/Projects 8Health News:China Holdings Announces Development on TaiHu and Ongniute Biomass Power Plants/Projects 9Health News:China Holdings Announces Development on TaiHu and Ongniute Biomass Power Plants/Projects 10
(Date:3/27/2015)... TEMPLE, Texas , March 27, 2015 The ... relocate in April to a 5,000-square-foot building at 1802 South ... a geographic area designated by the City of ... Baylor Scott & White and the Central Texas Veterans Health ... office and laboratory space to early stage biotechnology and life ...
(Date:3/27/2015)... March 27, 2015 Zimmer Holdings, Inc. (NYSE and SIX: ZMH) ... ® Complete Knee System. ... th year since Zimmer first introduced the NexGen knee ... date, more than five million implantations of the NexGen knee ... the NexGen knee demonstrates the importance of design innovation and ...
(Date:3/27/2015)... , March 27, 2015 CHINA ... Exhibition of Senior Care, Rehabilitation Medicine and Healthcare, second ... service industry, will be held at Shanghai New International ... 25 February, 2015,  Implementation Suggestions on Encouraging Private Capital ... which was jointly issued by the Ministry of Civil ...
Breaking Medicine Technology:Temple Health & Bioscience District Relocates, Offers Office And Lab Space To Biotech Companies 2Zimmer Celebrates Key Milestones For NexGen Complete Knee System 2CHINA AID, the 10th China International Exhibition of Senior Care, Rehabilitation Medicine and Healthcare to be held in April 2CHINA AID, the 10th China International Exhibition of Senior Care, Rehabilitation Medicine and Healthcare to be held in April 3CHINA AID, the 10th China International Exhibition of Senior Care, Rehabilitation Medicine and Healthcare to be held in April 4CHINA AID, the 10th China International Exhibition of Senior Care, Rehabilitation Medicine and Healthcare to be held in April 5CHINA AID, the 10th China International Exhibition of Senior Care, Rehabilitation Medicine and Healthcare to be held in April 6
... N.J., Jan. 3, 2012  Ikaria, Inc., a critical care ... critically ill patients in the hospital and ICU settings, ... program, the PRESERVATION I clinical trial, for its Bioabsorbable ... commenced in Australia, and will be followed in Europe.  ...
... 3, 2012 Reportlinker.com announces that a ... its catalogue: Transdermal Drug ... http://www.reportlinker.com/p0203552/Transdermal-Drug-Delivery---Technologies-Markets-and-Companies.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Delivery_Technology ... -Up-to-date one-stop information on transdermal drug ...
Cached Medicine Technology:Ikaria® Commences Global Registration Trial for Bioabsorbable Cardiac Matrix 2Ikaria® Commences Global Registration Trial for Bioabsorbable Cardiac Matrix 3Transdermal Drug Delivery - Technologies, Markets, and Companies 2Transdermal Drug Delivery - Technologies, Markets, and Companies 3Transdermal Drug Delivery - Technologies, Markets, and Companies 4Transdermal Drug Delivery - Technologies, Markets, and Companies 5Transdermal Drug Delivery - Technologies, Markets, and Companies 6Transdermal Drug Delivery - Technologies, Markets, and Companies 7Transdermal Drug Delivery - Technologies, Markets, and Companies 8Transdermal Drug Delivery - Technologies, Markets, and Companies 9Transdermal Drug Delivery - Technologies, Markets, and Companies 10Transdermal Drug Delivery - Technologies, Markets, and Companies 11
MRI curette, 8.5" overall length....
15" overall length, 5" handle....
10" overall length, 5" handle....
...
Medicine Products: